{"id":"W2171964208","doi":"10.3111/13696998.2012.667028","title":"Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thomson Reuters (Canada)","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Internal medicine; Tumor necrosis factor alpha; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002776897,0.0002266117,0.0003293479,0.0009840524,0.0002522036,0.0009712309,0.0004241257,0.0005041132,0.0006489695],"category_scores_gemma":[0.01177802,0.0002064038,0.000692289,0.001173254,0.0002130222,0.0007403807,0.0005090854,0.0005992525,0.0001327871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001142039,"about_ca_system_score_gemma":0.0005584155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006630812,"about_ca_topic_score_gemma":0.006521377,"domain_scores_codex":[0.9971403,0.001184662,0.0003896459,0.0004940975,0.0005801617,0.000211155],"domain_scores_gemma":[0.9840259,0.002945536,0.01165685,0.000394675,0.0005042492,0.0004728245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001637657,0.00002905256,0.9982863,0.000004578861,0.00004795812,0.00003425109,0.00004411003,0.0001417536,0.00004988482,0.000009958077,0.00004114766,0.001147223],"study_design_scores_gemma":[0.00002820102,0.0002465832,0.9968197,0.000009842497,0.00005440997,0.0003074557,0.0001106139,0.002067873,0.0001426068,0.00002080095,0.0001865217,0.000005374523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999199,0.0002255686,0.0001149139,0.00004150027,0.000001991969,0.00001009329,0.0002280422,0.000004620953,0.0001743049],"genre_scores_gemma":[0.9993623,0.00005401782,0.0001459476,0.00002293022,0.000008155976,0.000007899029,0.0003621354,9.337162e-7,0.00003574093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006630812,"threshold_uncertainty_score":0.01468575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0204339455573577,"score_gpt":0.2750843191235194,"score_spread":0.2546503735661617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}